Petros Grivas: Meet the Experts of VIRO 2025

The Global Voices in Renal Oncology (VIRO) Virtual Congress, organized by OncoDaily, will be held on September 11–12, 2025. Chaired by Dr. Rana R. McKay with co-chair Dr. Yüksel Ürün, this year’s program will feature around 50 leading experts in renal oncology from across the globe, sharing cutting-edge updates and future perspectives.

• The congress is free to attend.
• Register via the link.

Co-Chair of VIRO

Images

Name

Rana McKay Professor of Medicine and Urology at UC San Diego Health Co-leader of the GU Oncology Program at Moores Cancer Center As Co-Chair of VIRO, Dr. Rana McKay (University of California, San Diego) opened the congress with her talk on  “Future Directions: Emerging Agents and Combinations.” She emphasized the momentum in renal cell carcinoma (RCC) research, highlighting how novel immunotherapies, targeted drugs, and rational combination strategies are reshaping patient care. Dr. McKay underscored the importance of personalized, biomarker-driven approaches and global collaboration, aiming to optimize survival and quality of life worldwide.

Spotlight on Petros Grivas

Dr. Grivas is the Clinical Director of the Genitourinary (GU) Cancer Program at the University of Washington.

At the Global Voices in Renal Oncology (VIRO) Virtual Congress 2025, Dr. Grivas will present on “Making a Career in GU Oncology.” His talk will explore:

• The evolving landscape and opportunities in genitourinary oncology clinical practice and research.
• Key skills and career pathways for aspiring GU oncologists, including academic, clinical, and translational research roles.
• The importance of mentorship, collaboration, and leadership in building a successful oncology career.
• Advice on navigating clinical trials, precision medicine, and emerging therapies in GU cancers.
• Insights from his own career journey spanning academia, clinical care, and global oncology leadership.

Dr. Grivas combines clinical excellence with a passion for education and mentorship, inspiring the next generation of GU oncology specialists.

Global Voices in Renal Oncology (VIRO) 2025